French BioBeach supports San Diego Opera’s Life Sciences LIVE – at the Opera.
Feb 21, featuring elegant networking and The Elixir of Love by Donizetti. Details and tickets: www.sdopera.com/live
PLEASE JOIN US FOR THE 18TH Annual Life Sciences LIVE at the Opera
To learn more and registration, click here
Research in Industry Workshop
Friday, February 7, 2014. 1pm-3:30pm
The Salk Institute, Frederic de Hoffmann Auditorium
Host
San Diego Center for Systems Biology (SDCSB)
Organizer
Dr. Sumit Chanda, SBMRI
Description
This workshop will feature local leaders of Biotech and Pharma, who will describe research activities at their companies and provide insight towards career paths in industry. It will include presentations and a panel discussion.
For more information, click here.
|
|
|
Great start for French BioBeach in 2014 !
We are glad to announce that a Press Release will shortly come out regarding an agreement that will keep strengthening the ties we have created over the years between the French and San Diegan life science communities .. stay tuned ...
The BIO Exhibition is coming back to San Diego from June 23rd to 26st 2014, with as usual, a French Pavilion on the BIO Exhibitor hall as well as a special Fast-Track R&D partnering with France pre-BIO event. More info to come...
This month, as usual, our Breakfast and Happy Hour will take place to mingle but also a special focus on a local San Diego biotech event will be hosted with our partner WSGR.
And of course, a great event for the entire Life Science community which is Life Sciences Live at the Opera.
|
Reminder
Don't forget our monthly networking events !
When
Tuesday February 4th @ 8.30 am
Where
French BioBeach's office
4901 Morena Blvd, Suite 501
San Diego, CA 92117
Our croissants are generously provided by
And
Friday February 14th @ 5PM
Where
St Tropez Le Bistro
(former Wired cafe)
8935 Towne Centre Dr, San Diego, CA 92122
NEW THIS MONTH
Focus conference on a Biotech company !
Stay tuned for more info...
|
-
Ipsen implements a new governance in the United States to prepare for the launch of Somatuline® in oncology
Ipsen today announced new governance in the United States, following its recently announced decision to launch Somatuline® for oncology indications. Marc de Garidel will personally oversee this projected launch. To learn more, click here.
- MEDIAN Technologies Signs a EUR384K Contract with a San Francisco-area Biotech Company
MEDIAN Technologies, a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, today announced that it has signed a contract with ...
To learn more, click here.
-
Roger Guillemin 90th Birthday Symposium – January, 13, 2014 @ The Salk Institute for Biological Studies
Roger Guillemin, a distinguished Salk professor, received the Nobel Prize in 1977 for discoveries that laid the foundation for brain hormone research. Considered one of the founders of the field of neuroendocrinology, his work brought to light...
To learn more, click here.
-
Valneva Secures USD 30M New Financing and Confirms Sale of Clinical Manufacturing Operations in France
Lyon (France), December 9, 2013 – European Biotechnology company Valneva SE (Valneva) today announced that it has secured a USD 30 million financing from an investment fund managed by...
To learn more, click here.
|
Founded in 2011, Antibody Design Labs (ADL) is a products & services company committed to become a centralized place to access tools, information and techniques in the field of recombinant antibody generation, engineering and design. ADL current focus is on phage display, a key molecular biology technique to engineer polypeptides, with a rich offering of kits & reagents and construction of phage libraries, both antibodies and peptides as a service. Numerous products are in the development pipeline for 2014.
Philippe Valadon,
Member & Founder at ADL
Born in 1960. Medical degree and laureate of the Faculty of Medicine Necker–Enfants Malades, Paris in 1987. Ph.D. in Molecular Pharmacology at Pierre and Marie Curie University, Paris in 1992. Joined the Albert Einstein College of Medicine in New York as a research fellow in 1992; since then has followed an academic track focused on the molecular biology of antibodies, antibody engineering and antibody targeting of cancer, first at the Sidney Kimmel Cancer Center (San Diego) in 2000 and PRISM as an assistant professor in 2009.
|
Support to French BioBeach comes from your memberships. Renewing or starting a new French BioBeach membership is a way to express your support to our organization and to take advantage of the benefits offered by the membership.
|
|
|